OUR COMPANY
Rheonix, Inc. is exploiting its novel, patented, polymer chip microfluidic technology to introduce products that address some of the hottest issues in global healthcare today: Avian Influenza, HPV, TB, Dengue Fever, AIDS, SARS, bioterrorism, affordable healthcare in developing nations, personalized medicine, and molecular diagnostics, to name a few.
Rheonix is not predicated on creating new science; rather its business is bringing to commercial reality the long-promised potential of integrated microfluidic systems. Its unique polymer chip microfluidic technology has produced a wide variety of fluid-handling devices including channels, pumps, reaction vessels, diagnostic chambers, and combinations thereof. These devices enable the manipulation of small volumes of chemical and biological fluids, and, for the first time, the manufacture of low-cost, high-volume, widely-adoptable microfluidic products.
The versatility and scope of the Rheonix technology is well demonstrated in the field of molecular diagnostics. Rheonix has designed and fabricated on a single polymer chip (CARD™) all of the steps required to take a raw biological sample through cell lysis, nucleic acid extraction and purification, molecular amplification, and readout. We believe this to be an accomplishment no other technology or entity can claim.
Rheonix prides itself in having assembled a talented and dedicated group of professionals with significant experience in the biotechnology, medical instrumentation, and manufacturing sectors. Combined with its extensive intellectual property, the Company is set to provide novel solutions to today’s diagnostic challenges.
Having originated at Kionix, a global leader in the design and manufacture of high-performance, silicon micromachined MEMS inertial sensors, Rheonix benefits from the Kionix’s considerable intellectual property and expertise. The same dedication to cost-effective manufacturing that propelled Kionix into its market leading position is mirrored by Rheonix.
